Your browser doesn't support javascript.
loading
Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue.
Georgiadi, Anastasia; Lopez-Salazar, Valeria; Merahbi, Rabih El-; Karikari, Rhoda Anane; Ma, Xiaochuan; Mourão, André; Klepac, Katarina; Bühler, Lea; Alfaro, Ana Jimena; Kaczmarek, Isabell; Linford, Adam; Bosma, Madeleen; Shilkova, Olga; Ritvos, Olli; Nakamura, Nobuhiro; Hirose, Shigehisa; Lassi, Maximilian; Teperino, Raffaele; Machado, Juliano; Scheideler, Marcel; Dietrich, Arne; Geerlof, Arie; Feuchtinger, Annette; Blutke, Andreas; Fischer, Katrin; Müller, Timo Dirk; Kessler, Katharina; Schöneberg, Torsten; Thor, Doreen; Hornemann, Silke; Kruse, Michael; Nawroth, Peter; Pivovarova-Ramich, Olga; Pfeiffer, Andreas Friedrich Hermann; Sattler, Michael; Blüher, Matthias; Herzig, Stephan.
Afiliação
  • Georgiadi A; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany. anastasia.georgiadi@helmholtz-muenchen.de.
  • Lopez-Salazar V; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany. anastasia.georgiadi@helmholtz-muenchen.de.
  • Merahbi RE; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany. anastasia.georgiadi@helmholtz-muenchen.de.
  • Karikari RA; German Center for Diabetes Research (DZD), Neuherberg, Germany. anastasia.georgiadi@helmholtz-muenchen.de.
  • Ma X; Department for Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden. anastasia.georgiadi@helmholtz-muenchen.de.
  • Mourão A; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Klepac K; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Bühler L; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Alfaro AJ; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Kaczmarek I; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Linford A; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Bosma M; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Shilkova O; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Ritvos O; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Nakamura N; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Hirose S; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Lassi M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Teperino R; Department for Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
  • Machado J; Institute of Structural Biology, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Scheideler M; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Dietrich A; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Geerlof A; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Feuchtinger A; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Blutke A; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Fischer K; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller TD; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Kessler K; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Schöneberg T; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Thor D; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Hornemann S; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Kruse M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Nawroth P; Rudolf-Schönheimer-Institute for Biochemistry, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
  • Pivovarova-Ramich O; Institute for Diabetes and Cancer, Helmholtz Diabetes Center, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
  • Pfeiffer AFH; Joint Heidelberg-IDC Transnational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
  • Sattler M; Chair Molecular Metabolic Control, Medical Faculty, Technical University Munich, Munich, Germany.
  • Blüher M; German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Herzig S; Department for Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Nat Commun ; 12(1): 2999, 2021 05 20.
Article em En | MEDLINE | ID: mdl-34016966
ABSTRACT
The proper functional interaction between different tissues represents a key component in systemic metabolic control. Indeed, disruption of endocrine inter-tissue communication is a hallmark of severe metabolic dysfunction in obesity and diabetes. Here, we show that the FNDC4-GPR116, liver-white adipose tissue endocrine axis controls glucose homeostasis. We found that the liver primarily controlled the circulating levels of soluble FNDC4 (sFNDC4) and lowering of the hepatokine FNDC4 led to prediabetes in mice. Further, we identified the orphan adhesion GPCR GPR116 as a receptor of sFNDC4 in the white adipose tissue. Upon direct and high affinity binding of sFNDC4 to GPR116, sFNDC4 promoted insulin signaling and insulin-mediated glucose uptake in white adipocytes. Indeed, supplementation with FcsFNDC4 in prediabetic mice improved glucose tolerance and inflammatory markers in a white-adipocyte selective and GPR116-dependent manner. Of note, the sFNDC4-GPR116, liver-adipose tissue axis was dampened in (pre) diabetic human patients. Thus our findings will now allow for harnessing this endocrine circuit for alternative therapeutic strategies in obesity-related pre-diabetes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Proteínas / Receptores Acoplados a Proteínas G / Tecido Adiposo Branco / Proteínas de Membrana Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Proteínas / Receptores Acoplados a Proteínas G / Tecido Adiposo Branco / Proteínas de Membrana Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha